(Q34992771)

5 August 2017

1 reference

title

Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases (English)

1 reference

5 August 2017

5

Johan Auwerx

0 references

Laurent Dubuquoy

object named as

Laurent Dubuquoy

1

0 references

Pierre Desreumaux

object named as

Pierre Desreumaux

6

0 references

author name string

Sébastien Dharancy

2

1 reference

5 August 2017

Sophie Nutten

3

1 reference

5 August 2017

Sven Pettersson

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

360

1 reference

5 August 2017

1410-1418

1 reference

5 August 2017

9343

1 reference

A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

The pleiotropic functions of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Peroxisome proliferator-activated receptors: a critical link among fatty acids, gene expression and carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

PPARgamma and atherosclerosis: effects on cell growth and movement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

PPARS, metabolic disease and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on the expression of inflammatory cytokines and apoptosis induction in rheumatoid synovial fibroblasts and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Early de novo gene expression is required for 15-deoxy-Delta 12,14-prostaglandin J2-induced apoptosis in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Nuclear receptors. I. PPAR gamma in the gastrointestinal tract: gain or pain?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

A nuclear receptor to prevent colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

A unified nomenclature system for the nuclear receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

The organization, promoter analysis, and expression of the human PPARgamma gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Expression of peroxisome proliferator-activated receptor γ (PPARγ) in normal human pancreatic islet cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

PPARgamma in monocytes: less pain, any gain?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Evidence for the presence of peroxisome proliferator-activated receptor (PPAR) alpha and gamma and retinoid Z receptor in cartilage. PPARgamma activation modulates the effects of interleukin-1beta on rat chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Retinoic acid receptor gamma 2 gene expression is up-regulated by retinoic acid in 3T3-L1 preadipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Expression of retinoic acid receptor and retinoid X receptor subtypes in rat liver cells: implications for retinoid signalling in parenchymal, endothelial, Kupffer and stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Retinoic acid stimulates early cellular proliferation in the adapting remnant rat small intestine after partial resection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

RXRalpha overexpression in cardiomyocytes causes dilated cardiomyopathy but fails to rescue myocardial hypoplasia in RXRalpha-null fetuses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Myocardial retinoid X receptor, thyroid hormone receptor, and myosin heavy chain gene expression in the rat during adult aging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Expression of retinoid receptors during human monocyte differentiation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

RAR and RXR expression by Kupffer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

1,25-Dihydroxyvitamin D3 and retinoid X receptor expression in human colorectal neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Peroxisome proliterator-activated receptors, orphans with ligands and functions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

A one-vial method for routine extraction and quantification of free fatty acids in blood and tissue by HPLC

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

COX in a crystal ball: current status and future promise of prostaglandin research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

9-cis retinoic acid is a high affinity ligand for the retinoid X receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Therapeutic applications for ligands of retinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

The epidemiology and the pathogenesis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Inflammatory alterations in mesenteric adipose tissue in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Effect of troglitazone on exocrine pancreas in rats with streptozotocin-induced diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Peroxisome proliferator-activated receptors: structures and function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Thiazolidinediones: an update.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

International pharmacovigilance: developing cooperation to meet the challenges of the 21st century.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Etiopathogenesis of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2911395-X

7 January 2021

10.1016/S0140-6736(02)11395-X

Identifiers

DOI

1 reference

5 August 2017

1 reference